New Matches to Urologic Oncology Fellowship Program

Two urologists from California and New York are the newest members of Fox Chase Cancer Center’s Urologic Oncology Fellowship program—they have initiated their 2-year training this summer. The fellowship program annually matches 2 urology residents, providing a unique, higher level and comprehensive experience in the treatment of genitourinary cancers.

Selma Masic, MD, is a recent graduate of urology residency from the University of California San Francisco, and she is the first female urology fellow since Fox Chase started the fellowship program in 2008. “We are excited to be expanding the diversity of our program even more,” says David Y. T. Chen, MD, who oversees the fellowship program.

Masic was born in Yugoslavia and arrived in the U.S. when her family fled the war-torn country in 1994. She grew up in California, and is a graduate of the University of Southern California’s Keck School of Medicine.

The second fellow is Abhishek Srinastava, MD., who is a recent graduate of urology residency from Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx, NY. Previously, he was a research fellow at Weill Cornell Medical College in New York City studying urologic oncology outcomes at the college’s James Buchanan Brady Foundation Department of Urology. He started his education completing his medical degree in India, and initially served as a junior urology resident at Hindu Rao Hospital in New Delhi, India.

The new urologists join two second-year fellows: David Cahn, DO, who completed urology residency from Einstein Medical Center, in Philadelphia, and a graduate of Philadelphia College of Osteopathic Medicine, and Brian Kadow, who completed urology residency from the University of Pittsburg Medical Center, and a graduate of Loyola University’s Stritch School of Medicine.

This year the graduating fellows are Shreyas Joshi, MD, who is joining Fox Chase’s urology faculty, and Andres Correa, MD, who is joining the faculty at MD Anderson-Cooper Medical Center in Camden, New Jersey.

“The fellowship is a key collaboration,” says Chen “that gives urologists the opportunity to become experts in this field of cancer care and treatment, develop their clinical skills, and learn surgical skills that are unique and highly complex. In return, they bring their time and skills to conduct research in their second year, which contributes to Fox Chase’s tradition of discovering and developing new approaches to urologic cancer treatment.”

In addition, he says, the fellows contribute new ideas that they've encountered during their previous training so Fox Chase continues to evolve its care for all its patients.

Alexander Kutikov, MD, FACS, who was the first graduate of Fox Chase SUO urology fellowship program in 2010, says, “It is a huge privilege to train some of the brightest young mind in Urologic Oncology!”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427